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Abstract—Calprotectin is a member of the EF-hand proteins, composed of two subunits, S100A8 (MRP8)
and S100A9 (MRP14). These proteins are involved in important processes including cell signaling, regulation
of inflammatory responses, cell cycle control, differentiation, regulation of ion channel activity and defense
against microbial agents in a calcium dependent manner. In the present study, recombinant S100A8 and
S100A9 were expressed in E. coli BL21 and then purified using Ni-NTA affinity chromatography. The struc-
ture of the S100A8/A9 complex in the presence and absence of calcium was assessed by circular dichroism
and fluorescence spectroscopy. The intrinsic f luorescence emission spectra of the S100A8/A9 complex in the
presence of calcium showed a reduction in f luorescence intensity, reflecting conformational changes within
the protein with the exposure of aromatic residues to the protein surface. The far ultraviolet-circular dichro-
ism spectra of the complex in the presence of calcium revealed minor changes in the regular secondary struc-
ture of the complex. Also, increased thermal stability of the S100A8/A9 complex in the presence of calcium
was indicated.
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INTRODUCTION
Changes in the cytosolic calcium concentration
regulate a variety of cellular processes [1]. These
changes, act as a signal mediator, and the signal is
transduced as activation or inactivation of Ca2+ bind-
ing proteins including a large family of proteins char-
acterized by the EF-hand structural motif [2, 3]. S100
is a multigenic family of non-ubiquitous Ca2+-modu-
lated proteins of the EF-hand type expressed exclu-
sively in vertebrates and implicated in intracellular and
extracellular regulatory activities [4, 5]. S100A8 and
S100A9 are members of the S100 family characterized
by two calcium-binding sites with different affinity—a
high affinity site at the C terminus (EF-hand II) and a
low affinity site at the N terminus (EF-hand I) which
are f lanked by hydrophobic regions at either terminus
and separated by a central hinge region [6]. They are
specifically expressed in circulating neutrophils and
early differentiation stages of monocytes, as well as in
keratinocytes and epithelial cells under inflammatory
conditions [7]. The elevated level of intracellular cal-
cium also allows S100A8 and S100A9 to associate into
non-covalent heterodimers and translocate from the
cytosol to the cytoskeleton and the plasma membrane,
thus mediating calcium signals by binding to other intra-
cellular proteins [8]. The heterodimer of S100A8/A9
plays a crucial role in the regulation of inflammatory
processes and the immune response, cell cycle con-
trol, differentiation, regulation of ion channel activity,
apoptosis and defense against microbial agents [9–11].
Also increased serum levels of the heterodimer are
observed in several human diseases such as cystic
fibrosis, rheumatoid arthritis, acute inflammatory
lesions, cardiomyophathy, and formation and deposi-
tion of amyloids in the ageing prostate and Alzhei-
mer’s disease [12, 13]. More recently, they were also
detected in various human cancers [14, 15]. Calcium
induces conformational changes in calprotectin which
may allow its interaction with the target proteins [16].
These changes of conformation result in the exposure
of the hydrophobic surface for interactions with other
proteins [17–19].
The aim of this study focused on structural and
thermodynamic characterization of S100A8 and
S100A9 subunits and the role of calcium in their com-
plexation to form a dimer protein with new conforma-
tional changes and thus its different role as calprotectin.1 The article is published in the original.
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EXPERIMENTAL
Materials. Ni-NTA resin, Tris base, Acrylamide,
Isopropyl β-D-1-thiogalactopyranoside (IPTG) and
bacterial media (LB broth) were purchased from Sigma.
Ampicillin was obtained from Roch, sodium dihydrogen
phosphate (NaH2PO4), sodium chloride (NaCl), cal-
cium chloride (CaCl2), and all other reagents were
purchased from Merck chemical co. and imidazole
was purchased from applichem. Competent E. coli
strain Bl21 (DE3) and the pET15b vectors containing
an N-terminal His-Tag and the S100A8 or S100A9
coding sequence were obtained from Novagen. Other
reagents were of analytical grade.
Expression and purification of proteins (His6-
rhS100A8 and His6-rhS100A9). The pET15b expres-
sion vector, containing the coding region of S100A8 or
S100A9 was used to express the recombinant human
S100A8 (rhS100A8) or S100A9 (rhS100A9) in E. coli
BL21 (DE3). Ampicillin was used as the selective
marker for colonies carrying the recombinant vectors.
Single colonies of S100A8 and S100A9 were separately
cultured in Luria–Bertani medium containing 1%
ampicillin with vigorous shaking until OD 600 reached
to 0.5–0.6 at 37°C. 1 mM IPTG was added to the cul-
ture, and the induction was carried out at 37°C. Then
the cells were harvested by centrifugation at 5000 g for
15 min. The cells were lysed with the lysis buffer
(Glycerol 10%, HEPES 25 mM, NaCl 100 mM, pH 8)
then sonicated and centrifuged at 16000 g for 30 min.
The supernatant containing each of the soluble His-
tagged subunits was purified by Ni+2-NTA affinity
chromatography. Then dialyzed against imidazole in
buffer (NaCl 100 mM, NaH2PO4 25mM, pH 6.5) at
4°C for 12h, then the soluble protein was saved at
‒80°C. The concentrations of recombinant proteins
were determined according to the Bradford method
with bovine serum albumin as the standard [20]. Pro-
tein measurements were also accomplished using
Nono Drop spectrophotometry.
CD spectroscopy. CD spectra were recorded from
195 to 260 nm in a 0.1 cm cuvette on a J815 spectropo-
larimeter (Jasco) which was used to obtain the CD
data of regular secondary structures of r-S100A8/A9.
The fraction of alpha-helix to beta-sheet was deter-
mined utilizing CD Deconvolution software. r-S100A8
and r-S100A9 were mixed 1 : 1 in equimolar concen-
trations and incubated with calcium chloride (1 mM)
for 1 hour at room temperature forming the dimer pro-
tein. All CD spectra were obtained from protein sam-
ples dissolved in a 100 mM NaCl and 25 mM NaH2-
PO4 buffer at pH 6.5 with protein concentrations of
about 15–25 μM for a path length of 0.1 cm. Spectra
were corrected for the buffer and converted to molar
CD per residue before analysis. The results were
expressed as molar ellipticity (deg cm2/dmol) consid-
ering the mean number of residues as 207 and an aver-
age molecular weight of 38 kDa for the S100A8/A9
complex. The molar ellipticity was determined as [θ] =
λ[100(MRW) × θobs/(c × l)], where θobs is the observed
ellipticity in degrees at a given wavelength, c is the pro-
tein concentration in mg/mL and l, is the length of the
light path in cm.
Fluorescence spectroscopy. Intrinsic f luorescence
spectra of the purified protein samples were obtained
using a Cary Eclips spectrophotometer (Varian, Salt
Lake, Australia). Samples were excited at 280 nm and flu-
orescence intensities were collected from 300 to 450 nm.
The spectra were obtained with 0.1 to 0.15 mg/mL
protein samples dissolved in a 100 mM NaCl and 25 mM
NaH2PO4 buffer at pH 6.5 at room temperature. The
presence of a single tryptophan residue in both
S100A8 and S100A9 allows to analyze these proteins
by f luorescence spectroscopy.
Thermal denaturation studies. The effect of increas-
ing temperature on the structural integrity of S100A8
and S100A9 subunits and their calcium induced com-
plexes were studied by following the changes in the
fluorescence emission intensity at 337 nm(λ max), in
a range from 20 to 90°C, using a Cary Eclips spectropho-
tometer (Varian, Salt Lake, Australia). All spectra were
obtained from protein samples dissolved in a 100 mM
NaCl and 25 mM NaH2PO4 buffer at pH 6.5.
RESULTS
Expression and Purification
S100A8 and S100A9 were separately expressed as
recombinant proteins in pET15b and E. coli BL21
(DE3) system using IPTG as the inducer. Protein
expression was achieved after 4 hours of induction at
37°C and purification was accomplished at 150 mM
imidazole. Expression and homogeneity of recombi-
nant proteins were demonstrated by SDS-PAGE as
two distinct bands indicated in Fig. 1.
Far UV-CD Studies of r-S100A8/A9 Complex
It has been proven that CD spectroscopy is an ideal
technique for monitoring the transitional switch
between regular secondary structures in proteins,
which can occur as a result of changes in experimental
parameters such as binding of ligands [21, 22]. Typi-
cally, the CD spectra of proteins are recorded in the
far-UV region (180–250 nm) and the near-UV region
(250–320 nm). An advantage of the CD technique in
studies of proteins is that complementary structural
information can be obtained from a number of spectral
regions. The far-UV CD spectrum is directly related to
the protein’s secondary structure and near-UV CD is
characteristic of the tertiary protein structure [23, 24].
Circular dichroism (CD) spectroscopy was carried out
to show changes in the secondary structures of the
recombinant S100A8/S100A9 when calcium ions are
present. As shown in Fig. 2 and Table 1, the results
indicate at a high degree of α-helix which is character-
istic of EF- hand proteins [25]. Also the secondary
120
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structure was different in the presence of 1 mM cal-
cium (Fig. 2 and Table 1). The CD data confirmed a
reduction in α-helix content and an increase in β- and
other structures of human S100A8/A9 complex in the
presence of calcium (Fig. 2 and Table 1).
The Internal Fluorescence of S100A8 and S100A9 
Subunits
Fluorescence spectroscopy is a useful technique to
study the structure, dynamics, and binding properties
of protein molecules in solution. Conformational
changes within protein molecules after binding of
ligands can be monitored by f luorimetric measure-
ments [26]. The f luorescence of a protein is caused by
three intrinsic f luorophores present in the protein,
i.e., the Trp, Tyr and Phe residues. Actually, the
intrinsic f luorescence of many proteins is mainly con-
tributed to by tryptophan [27]. There are several aro-
matic residues present in each subunit of the human
calprotectin (Trp54, Tyr16, Tyr19, Tyr30, and Tyr54 in
S100A8, and Trp88 and Tyr22 in S100A9 [28]. A sig-
nificant reduction in the f luorescence intensity of the
human S100A8/A9 complex was seen (Fig. 3), reflect-
ing a conformational change within the protein, or
quenching of f luorescence emission of the aromatic
residues in the presence of calcium might indicate the
exposure of aromatic residues to the solvent. There-
fore, the emission spectra of human calprotectin in the
presence of calcium suggest a change in the tertiary (or
quaternary) structure and exposure of the hydropho-
bic groups of the protein to the solvent.
Thermal Denaturation Analysis
Determination of the Gibbs free energy of denatur-
ation (ΔG°), as a criterion of conformational stability
of a globular protein, is based on the theory of two
states as follows:
Native (N) ⇔ Denatured (D).
This theory was developed by Pace et al [29, 30].
The process was described as a single denaturant-
dependent step according to the two-step theory [31].
The denaturation process can be monitored based on
the changes in the absorbance at 280 nm. Then the
fraction of the denatured protein (Fd) as well as the
equilibrium constant of the process (K) can be calcu-
lated using Equations 1 and 2, respectively:
Fd = (YN –Yobs)(YN – YD) – 1, (1)
K = Fd(1 – Fd) – 1 = (YN – Yobs)(Yobs – YD) – 1, (2)
Fig. 2. Far UV circular dichroism spectrum for S100A/A9
complex in the absence (s) and presence of Ca2+ (d). The
CD spectrum was obtained from a 0.2 mg/ml protein sam-
ple dissolved in a 100 mM NaCl, 25 mM NaH2PO4 buffer
at pH 6.5 and 25°C. 
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Table 1. Percentages of secondary structures in the
S100A/A9 complex in the absence and presence of Ca2+
Secondary structures, %
Group α-sheet β- structure other structure
S100A8/A9 36.8 ± 2.4 14.7 ± 5.2 50.0 ± 0.8
S100A8/A9 + Ca2+ 28.6 ± 1. 6 19.7 ± 3.3 52.2 ± 2.6
Fig. 1. SDS-PAGE of purified His6-tagged S100A8 and
S100A9. Lane 1 contains the high molecular weight
marker, Lanes 2 and 3 show purified r-S100A8 and r-S100A9
respectively. Lane 4 shows both subunits.
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where Yobs is the observed variable parameter (e.g.,
absorbance value) and YN and YD are the values of Y
characteristic of a fully native and denatured confor-
mation, respectively. Then the Gibbs free energy
change (ΔG°) can be obtained by Equation 3:
ΔG° = –RT lnK, (3)
where R is the universal gas constant and T is the abso-
lute temperature. By plotting ΔG° versus temperature,
protein stability at any temperature, for example, at
room temperature of 25°C (ΔG° 298), can be obtained
[32]. Figure 4 shows the free energy changes versus
temperature in the S100A8/A9 complex in the absence
and presence of Ca2+. The thermodynamic parame-
ters are calculated and summarized in Table 2. The
obtained results reveal that, thermal stability parame-
ters (ΔG and Tm) of r-S100A8/A9 have increased in the
presence of calcium (Figs. 4, 5).
The Gibbs free energy change (ΔG°) was obtained
using the equation ΔG° = –RT lnK, where R is the uni-
versal gas constant and T is the absolute temperature.
By plotting ΔG° versus temperature, protein stability at
any temperature, (ΔG°), can be obtained.
DISCUSSION
In this study, the S100A8 and S100A9 subunits
were expressed and purified successfully. They showed
different secondary and tertiary structures in their sole
forms, but their incubation with calcium induced the
dimerization of the two subunits and changes in struc-
tural and the thermodynamic stability. Although stud-
ies support that each subunit may have its own individ-
ual functions, the general consensus is that the protein
function is dependent on the heterodimer formation
[28]. It is reported that homo-oligomeric forms of
S100A8 and S100A9 are readily degraded by proteases,
but the hetero-oligomeric S100A8/A9 complex dis-
plays a high resistance even against proteinase K deg-
radation [33, 34]. Thermal denaturation of the dimer
complex showed higher magnitudes of ΔG 25°C and
Tm of the calcium-bound protein in comparison with
its free form (Table 2). Binding to calcium is modu-
lated by two EF-hands in each subunit. EF-hands
have a helix-loop-helix structure and form stable
structural domains in interacting pairs and typically
undergo a conformational change upon Ca2+ binding
[17]. There is a large change in the position of the helix
HIII upon Ca2+-binding [34]. The inter helical angle
between helices HIII and HIV changes by 90° in
S100B compared to the Ca2+-free structure, opening
the structure and exposing the residues required for
target recognition and binding. This is also described
as a change from the closed conformational state in the
absence of Ca2+ to the open conformational state in its
presence, as indicated for calmodulin and troponin C
[17]. As indicated in this study, the calcium containing
complex induced a conformational change in the
dimer or an increase in the hydrophobic patch. As a
result, two large hydrophobic surfaces are exposed for
Table 2. Thermodynamic parameters of thermal stability
analysis of S100A8/A9 complex in the absence and presence
of Ca2+
Group Tm, °C ∆GU, kJ/mol
S100A8/A9 73.4 ± 1.3 29 ± 1.2
S100A8/A9 + Ca2+ 75.6 ± 0.98 33 ± 0.2
Fig. 3. Intrinsic fluorescence emission spectra of r-S100A8/A9
complex in the absence (– –) and presence of Ca2+. The
spectra were obtained from 0.15 mg/mL protein sample dis-
solved in a 100 mM NaCl, 25 mM NaH2PO4 buffer at pH 6.5
at room temperature. 
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target interaction. The alteration of the molecular sur-
face and the electrostatic potential provides several
mechanistic explanations for how the calcium-bind-
ing domain could be involved in mediating resistance
to bacterial invasion [10]. Recently a new property of
S100A8 and S100A9 was discovered—their ability to
self-assemble into highly heterogeneous amyloid com-
plexes, encompassing both oligomeric species and
highly stable fibrils able to grow and accumulate in the
ageing prostate [12]. Our results demonstrated a minor
shift in helical content transition in to β-sheet (data
not shown). This was reported previously by Yousefi
et al. as indicated in the mentioned study, this confor-
mational change could induce calprotectin prone to
aggregation at higher calcium concentrations [26].
Also the conformational transition, helix to β-sheet, is
related to formation of amyloid plaques in some dis-
eases like Alzheimer’s, prion disease, aging prostate
[13, 35, 36]. In prion disease, partial misfolding of PrP
converts into a partially protease-resistant disease
associated isoform, PrPc, which aggregates in the
brain and forms deposits that are associated with the
neurodegenerative changes [35].
It is identified that, the expression of S100A8 and
S100A9 are enhanced in human prostate cancer. High
intrinsic amyloid-forming capacity of the S100A8/A9
proteins may lead to their amyloid depositions in
numerous ailments [12]. The calcification of amyloid
deposits occurring in the prostate lead to their further
stabilization, which is particularly important in the
protease rich prostate f luid. Indeed, the mineral con-
tent of corpora amylacea indicates that calcification
can be a regulating process. It is important to note
that, S100A9 itself can serve as a promoter of the dys-
trophic calcification process as it has been shown in
thermogenesis [37].
Our results revealed that, binding to calcium ions
has an effect on secondary and tertiary structures of
r-S100A8/A9 complex which might be necessary to
obtain its biological function. Also thermal stability of
the S100A8/A9 complex was elevated in the presence
of calcium.
We are grateful to the deputy of research and tech-
nology of the Qazvin University of Medical Sciences
for financial support of this work.
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